top of page

Observatory Master Class

New Era of Medicine - Clinical Application of Stem Cells


October 13-14, 2017


Seoul, South Korea 


Mark Berman MD, USA

Hee Young Lee MD, South Korea

Kotaro Yoshimura MD, Japan 


Cell Surgical Network 

Master Class Registration: 

1,000 USD 

*IFAAS Members collect 5% Credit Rebate to be utilised for all future IFAAS events



Day 1 October 13, 2017 


13:00-13:30  Check-in at the office of Dr Hee Young Lee, change into scrubs


13:30-14:30  Live Cell Surgical Demonstration:

  • Learn step by step how to harvest and begin processing of stromal vascular fraction (SVF, loaded with adipose derived stem cells) in accordance with the Cell Surgical Network's IRB approved protocols.

Mark Berman MD, USA & Hee Young Lee MD, South Korea


14:30 - 15:00  Stem Cell Biology Lecture 

Mark Berman MD, USA


15:00-16:00  Live Cell Surgical Demonstration continued: 

  • Learn step by step the remainder of the SVF processing techniques in compliance with IRB approved protocols. 

  • See how the isolated SVF (stem cells) are deployed into a patient. 

Mark Berman MD, USA & Hee Young Lee MD, South Korea

16:00-17:00  Pursuing the Future of Medicine:

  • How to uniformly collect patient baselines and follow ups to understand the safety and effects of SVF

  • A history of SVF and how we are shaping the future

Mark Berman MD, USA



Day 2  October 14, 2017 


09:30 - 10:00   Registration 


10:00-10:30   Welcome and Introduction

  • Learn about the history of clinical applications of stem cells, how we have come to where we are today, and where regenerative cell based medicine is headed in the future.

  • Understand how your patients’ fat could be the key to their longevity and how cellular based medicine is changing how we treat chronic and acute conditions.

Mark Berman MD, USA

10:30 - 11:30   The Science and a Cellular Understanding of Stromal Vascular Fraction and its Components

  • SVF is a complex orchestra of cellular components that happens to be loaded with adipose derived mesenchymal stem cells, hematopoietic stem cells, white and red blood cells.

  • Discover how these stem cells are able to home in on sites on inflammation, modulate the immune system, replicate, and differentiate.

  • Learn what cytokines (growth factors) might be present in SVF, and why every patient’s SVF will be unique.

Kotaro Yoshimura MD, Japan 

11:30 - 12:00   Deploying SVF for Orthopedics, Urology, and even Cancer?

  • Discover how the regenerative characteristics of autologous stem cells are being deployed for a number of cellular degenerative conditions.

  • Deployments have been as simple as intra-articular and IV infusions, but even include intracerebralventricular injections of SVF.

Mark Berman MD, USA

12:00 - 13:00   Lunch & Networking


13:00 - 13:30  Mitigating the Effects of Concussion, Spinal Cord Injury and Neurological Disorders with SVF

  • Much laboratory and clinical research has been done with SVF showing its efficacy in treating neurological injuries, diseases and spinal cord injuries.

  • Often considered some of the most difficult conditions to treat, the findings of these studies will be reported on.

Mark Berman MD, USA

13:30-14:00  Stromal Vascular Fraction for Plastic Applications

  • Hear how SVF can be used in plastic surgery applications. SVF was originally added to fat and grafted as part of the CAL treatment (Cell Assisted Liposuction).

  • In the years since this procedure was developed, Dr. Lee has been pioneering different ways of using autologous and expanded adipose derived stem cells for plastic uses.

Hee Young Lee MD, South Korea

14:00-14:30  Review of Regulatory Issues in Cell Surgery and Cell Medicine

  • The FDA has issued many statements on stem cells. From statements, to regulations, guidances, and everything in between, the rules and regulations surrounding this new era of medicine can be confusing.

  • Dr. Berman discusses the history of the FDA’s authority, their mandates, the reasons behind their guidances and ultimately where the world regulatory agencies stand on cell surgery and cell medicine in 2017.

Mark Berman MD, USA

14:30 – 15:00  The Importance of Collecting Clinical Data and How To Do So Easily

  • It is critical that we understand the effects of stem cell surgery and report on its safety and outcomes. An established database to gather patients’ baseline data and track their clinical outcomes is the only responsible way to go forward in this new era of medicine.

Mark Berman MD, USA

15:00 - 15:30   Q&A 

Mark Berman MD, USA, Hee Young Lee MD, South Korea & Kotaro Yoshimura MD, Japan 

15:30 - 17:00 Break and Mingling

17:00 - 18:00 Cocktails Event: Cell Surgical Network Presentation

The Cell Surgical Network has been leading the way in investigating clinical stem

cell deployments for a number of cellular degenerative conditions. CSN operates

under IRB approved protocols and collects all of their patient data in a HIPPA

compliant online database, where safety and outcomes can be gathered,

quantified, and studied.

6:00pm-9:00pm Cocktail Event


Mark Berman MD, United States 







Dr Berman practices cosmetic surgery and stem cell surgery in Beverly Hills. Together with Elliot Lander, they co-founded the California Stem Cell Treatment Center and then the Cell Surgical Network. There are about 100 affiliates and growing in the US and growing rapidly with partners in China and worldwide.  Recently, they formed Cells on Ice in the USA for cell banking and cell expansion.  He was the 2010 President of the American Academy of Cosmetic Surgery.  He’s a clinical professor at the University of Southern California.  The Academy of Regenerative Practices named him #3 of the top 10 stem cell innovators.

Hee Young Lee MD, South Korea 










In recent years, Dr. Hee Young Lee of South Korea has made important contributions with fat grafting.  Dr. Lee’s stem cell expansion and storage system allows researchers to augment two ounces of a patient’s adult fat into billions of adult stem cells and then stores the stem cells. Dr. Lee Hee-Young, who has been working as a plastic surgeon for more than 20 years plays a leading role in inventing and developing medical equipment tailored to meet the needs of medical personnel.

Kotaro Yoshimura MD, Japan 








Kotaro Yoshimura. M.D. is a professor and chairman of Department of Plastic Surgery at Jichi Medical University, Japan. He received his medical degree and doctorate from University of Tokyo. After returning from research work at University of Michigan, he worked for University of Tokyo and directed his laboratory. His research interests cover skin/hair/scar biology, wound healing/angiogensis, and regenerative medicine. 

He published more than 150 full articles published in medline-indexed journals as well as several textbook chapters and was awarded by American Society of Plastic Surgeons (ASPS) as a 38th Maliniac Lecturer in 2016. Prof. Yoshimura is currently Asian Liaison of Plastic Surgery Research Council (PSRC) and a founding member and vice president of ISPRES.

bottom of page